The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of programmed death receptor-1 (PD-1) blockade in metastatic uveal melanoma (UM).
 
Katy K. Tsai
No Relationships to Disclose
 
Alexander Noor Shoushtari
Consulting or Advisory Role - Castle Biosciences; Vaccinex
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Rodrigo Ramella Munhoz
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Lilly
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Zeynep Eroglu
No Relationships to Disclose
 
Josep M. Piulats
No Relationships to Disclose
 
Patrick Alexander Ott
Consulting or Advisory Role - Alexion Pharmaceuticals; Amgen; Bristol-Myers Squibb
Research Funding - ARMO BioSciences; AstraZeneca; Bristol-Myers Squibb
 
Douglas Buckner Johnson
Consulting or Advisory Role - Bristol-Myers Squibb; Genoptix
 
Jimmy Hwang
No Relationships to Disclose
 
Adil Daud
Stock and Other Ownership Interests - Oncosec
Consulting or Advisory Role - GlaxoSmithKline; Merck; Oncosec
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck/Schering Plough (Inst); oncosec (Inst); Pfizer (Inst)
 
Jeffrey Alan Sosman
Honoraria - Amgen; Merck
Consulting or Advisory Role - Amgen; Merck
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Novartis (Inst)
 
Richard D. Carvajal
Consulting or Advisory Role - AstraZeneca; Aureon Biosciences; Genentech; Iconic Therapeutics; Janssen; Merck; Novartis; Thomson Reuters
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celldex (Inst); Daiichi Sankyo (Inst); Genentech (Inst); Immunocore (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Reflexion Medical (Inst)
 
Bartosz Chmielowski
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb; Lilly (Inst)
Speakers' Bureau - Genentech/Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech/Roche; Lilly
 
Michael Andrew Postow
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Jeffrey S. Weber
Stock and Other Ownership Interests - Altor BioScience; Celldex; Merck
Honoraria - Abbvie; Altor BioScience; Amgen; AstraZeneca; Bristol-Myers Squibb; Celldex; Daiichi Sankyo; Eisai; Genentech; GlaxoSmithKline; Ichor Medical Systems; Lion Biotechnologies; Merck; Merck; Pieris Pharmaceuticals; Roche
Consulting or Advisory Role - Abbvie; Altor BioScience; Amgen; AstraZeneca; Bristol-Myers Squibb; Celldex; Daiichi Sankyo; Eisai; Genentech; GlaxoSmithKline; Ichor Medical Systems; Lion Biotechnologies; Merck; Merck; Pieris Pharmaceuticals; Roche
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Merck (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; Celldex; Daiichi Sankyo; Genentech; GlaxoSmithKline; Lion Biotechnologies; Merck; Merck; Pieris Pharmaceuticals; Roche
 
Ryan J. Sullivan
Consulting or Advisory Role - Astex Pharmaceuticals; Biodesix; Novartis; Prometheus
Other Relationship - Boehringer Ingelheim
 
Alain Patrick Algazi
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Oncosec (Inst)